Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm

Ann Oncol. 2017 Mar 1;28(3):673-675. doi: 10.1093/annonc/mdw655.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents, Immunological / adverse effects*
  • Antineoplastic Agents, Immunological / therapeutic use
  • Diaphragm / drug effects*
  • Diaphragm / pathology*
  • Humans
  • Male
  • Melanoma / drug therapy
  • Myositis / chemically induced*
  • Myositis / pathology
  • Respiratory Insufficiency / chemically induced*
  • Respiratory Insufficiency / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab